denc
multipl
sclerosi
infect
clin
microbi
rev
johnson
rt
chronic
inflammatori
demyelin
diseas
p
viral
infect
nervou
system
lippincottraven
philadelphia
new
york
sibley
wa
cr
bamford
k
clark
clinic
viral
infect
multipl
sclerosi
lancet
andersen
et
al
viral
infer
tion
trigger
multipl
sclerosi
relaps
prospect
seroepideauiolog
studi
j
neurol
clostridium
cile
associ
case
pseudomembran
coliti
antibioticassoci
coliti
antibioticassoci
case
diarrhea
asymptomat
carriag
thought
twoto
fivefold
common
diseas
organ
produc
two
exotoxin
toxin
thought
respons
gastrointestin
symptom
seen
function
enterotoxiq
toxin
b
potent
cytotoxin
work
definit
c
icileassoci
diseas
cdad
includ
diarrhea
defin
least
six
wateri
stool
h
three
unform
stool
h
day
eight
unform
stool
h
ii
pseudomembran
seen
endoscopi
lower
gastrointestin
tract
detect
toxin
toxigen
organ
stool
iii
recogn
etiolog
diarrhea
iv
histori
treatment
antimicrobi
antineoplast
agent
within
previou
week
respons
specif
therapi
cdad
mani
antimicrobi
antineoplast
agent
demonstr
induc
cdad
common
antimicrobi
agent
clindamycin
ampicillin
amoxicillin
cephalosporin
diagnosi
cdad
import
diseas
sever
major
nosocomi
problem
varieti
method
current
avail
laboratori
diagnosi
cdad
includ
cell
cultur
assay
presenc
cytotoxin
anaerob
cultur
stool
organ
follow
test
product
toxin
toxigeni
cultur
latex
agglutin
detect
c
dr
kileassoci
antigen
stool
enzym
immunoassay
eia
detect
toxin
toxin
b
eia
format
includ
microdilut
immunochromatograph
test
rapid
laboratori
diagnosi
cdad
highli
desir
set
hospit
cost
contain
make
eia
detect
toxin
stool
specimen
desir
test
option
reason
mani
laboratori
perform
eia
detect
toxin
stool
specimen
tabl
show
result
recent
email
survey
clinic
microbiologist
tirn
laboratori
across
unit
state
respond
clinic
microbiolog
labomtori
rang
size
small
laboratori
serv
singl
hospit
bed
larg
laboratori
serv
multipl
hospit
total
bed
clear
major
respond
perform
eia
primari
assay
diagnosi
cdad
multitud
concern
question
exist
laboratori
diagnosi
cdad
major
concern
assay
perform
primari
test
laboratorian
must
first
decid
analyt
test
whether
organ
cultur
antigen
toxin
format
cell
line
microdilut
plate
immunochromatographi
best
fit
workflow
suit
demand
custom
articl
present
data
may
intluenc
decis
toxin
analyt
discuss
perform
characterist
individu
test
kit
decis
specif
test
kit
use
made
follow
thorough
literatur
search
inhous
comparison
studi
present
data
help
laboratorian
avoid
repeat
test
request
detect
c
cile
toxin
asymptomat
patient
primari
assay
diagnosi
c
cile
diseas
cytotoxin
assay
toxin
b
sought
stool
specimen
case
report
literatur
toxin
b
genedefici
isol
associ
cdad
patient
report
clearli
diarrhea
c
cile
isol
patient
stool
pcr
primer
pair
use
investig
demonstr
presenc
toxin
gene
toxin
b
genespecif
primer
fail
promot
amplif
portion
toxin
b
gene
design
recogn
thu
least
portion
toxin
b
gene
miss
isol
c
ciie
interestingli
author
case
report
impli
cytotoxin
assay
posit
patient
episod
toxin
bdefici
c
dffficil
isol
obtain
therefor
appear
diagnosi
cdad
caus
organ
isol
made
use
cytotoxin
assay
also
possibl
patient
infect
two
differ
strain
c
difficil
one
toxin
bdefici
one
present
time
detect
toxin
b
alon
suffic
diagnosi
cdad
laboratori
reli
assay
detect
toxin
alon
may
want
reconsid
choic
assay
diagnos
cdad
isol
lack
portion
toxin
gene
known
time
organ
thought
unabl
caus
diseas
human
evid
isol
caus
diseas
begin
surfac
case
pseudomembran
coliti
caus
toxin
aneg
toxin
bposit
strain
c
dtfzcile
recent
report
seattl
wa
stool
specimen
patient
gave
neg
result
toxin
eia
posit
result
cytotoxin
assay
pcr
perform
use
dna
extract
c
ecil
strain
isol
patient
stool
demonstr
truncat
delet
toxin
gene
miss
portion
gene
code
epitop
epitop
react
monoclon
antibodi
ela
use
detect
toxin
stool
two
recent
describ
nosocomi
outbreak
cdad
caus
toxin
aneg
toxin
bposit
strain
c
iciz
first
report
winnipeg
manitoba
canada
describ
outbreak
involv
patient
antibioticassoci
diarrhea
pseudomembran
coliti
lo
routin
diagnost
test
use
hospit
laboratori
diagnosi
cdad
eia
detect
toxin
alon
index
case
patient
high
clinic
suspicion
cdad
whose
stool
neg
c
kile
toxin
three
separ
occas
test
enzym
immunoassay
toxin
diagnosi
cdad
made
use
cytotoxin
assay
next
week
three
addit
patient
similar
present
stool
specimen
neg
toxin
eia
posit
cytotoxin
assay
remain
case
identifi
use
toxin
eia
neg
eia
capabl
detect
toxin
b
posit
cytotoxigen
c
dqj
ciie
isol
ident
pulsedfield
gel
electrophoresi
pattern
isol
seven
patient
pcr
analysi
demonstr
seven
isol
delet
carboxi
repetit
oligopeptid
region
toxin
gene
encod
epitop
recogn
antibodi
toxin
eia
use
diagnost
test
c
ciie
second
outbreak
report
meibergdreef
amsterdam
toxin
aneg
toxin
bposit
infect
recogn
uniqu
cytotox
effect
organ
produc
cytotoxin
assay
describ
previous
kato
et
al
discret
cluster
round
cell
seen
rather
cell
round
disrupt
celltocel
contact
display
toxinaposit
toxin
bposit
strain
outbreak
involv
patient
whose
symptom
rang
mild
sever
one
death
occur
ident
pcr
ribotyp
arbitrarili
prime
pcr
pattern
identifi
isol
patient
involv
outbreak
four
repres
isol
toxin
aneg
strain
truncat
toxin
gene
kb
smaller
expect
four
isol
gave
neg
result
test
product
toxin
eia
detect
toxin
alon
report
describ
demonstr
toxin
aneg
toxin
bposit
organ
caus
diseas
presenc
organ
stool
specimen
detect
use
eia
detect
toxin
alon
common
isol
often
caus
diseas
question
still
unansw
japan
kato
et
al
report
isol
organ
symptomat
children
asymptomat
children
asymptomat
adult
burday
et
al
report
incid
stool
specimen
toxin
neg
eia
posit
toxin
b
eia
two
hospit
new
jersey
initi
report
kato
et
al
case
report
two
outbreak
discuss
earlier
indic
organ
found
worldwid
report
make
clear
test
toxin
alon
may
lead
undiagnos
case
outbreak
cdad
therefor
test
toxin
alon
without
risk
laboratori
test
toxin
alon
consid
switch
cytotoxin
assay
assay
detect
toxin
b
biosit
triag
c
difficil
panel
biosit
diagnost
san
diego
ca
simultan
detect
toxin
c
difficil
common
antigen
glutam
dehydrogenas
laboratori
use
assay
expect
frequent
see
test
result
common
antigen
posit
panel
sensit
common
antigen
toxin
also
organ
produc
neither
toxin
b
common
environ
stool
specimen
use
biosit
triag
test
requir
laboratori
second
assay
interpret
toxin
aneg
commonantigenposit
result
confirmatori
assay
cytotoxin
assay
eia
detect
toxin
b
repeat
test
order
physician
account
signific
number
test
request
c
zcize
toxin
assay
receiv
laboratori
rensbaw
et
al
report
repeat
test
within
day
initi
request
account
c
cile
cytotoxin
assay
request
easi
laboratori
reject
repeat
test
request
patient
whose
previou
c
kile
toxin
test
posit
regardless
assay
laboratori
use
societi
healthcar
epidemiolog
america
shea
posit
paper
summar
analyz
result
mani
publish
studi
say
testofcur
cultur
toxin
assay
follow
treatment
recommend
imperfect
predictor
subsequ
relaps
shea
also
believ
patient
consid
therapeut
failur
receiv
least
day
treatment
opinion
cite
laboratori
reject
repeat
test
request
within
day
previou
posit
result
cytotoxin
assay
assay
publish
data
concern
reject
repeat
request
follow
initi
neg
result
studi
publish
renshaw
et
al
aptli
name
lack
valu
repeat
clostridium
cile
cytotox
assay
renshaw
et
al
describ
episod
two
cytotox
assay
repeat
within
day
initi
request
repeat
test
provid
use
inform
chang
fom
neg
posit
case
author
conclud
c
cile
cytotox
assay
repeat
within
period
retrospect
review
reveal
request
c
diftfcil
cytotoxin
assay
repeat
test
within
day
previou
request
use
inform
obtain
repeat
test
despit
move
cytotoxin
assay
toxin
b
eia
perform
well
inhous
comparison
cytotoxin
cultur
decid
institut
rule
repeat
test
within
day
institut
physician
want
repeat
test
must
call
laboratori
prevent
reject
request
intens
care
unit
ask
includ
implement
rule
saw
decreas
number
test
per
patient
may
june
perform
toxin
b
eia
test
receiv
set
stool
specimen
two
request
c
kile
toxin
test
set
provid
clinic
use
result
feel
reject
criteria
success
encourag
other
institut
polici
laboratori
may
ask
search
c
di
icil
toxin
stool
specimen
form
stool
fom
asymptomat
patient
effort
identifi
isol
even
treat
carrier
tri
control
spread
nosoco
mial
cdad
caregiv
infect
control
practition
may
infhrenc
recent
articl
publish
american
journal
infect
control
describ
polici
identifi
readmit
patient
posit
c
dl
kile
within
past
month
patient
place
isol
test
presenc
c
dijkil
toxin
patient
whose
stool
specimen
toxin
neg
remov
isol
toxinposit
patient
remain
isol
treat
cdad
gener
day
oral
metronidazol
although
author
attriiut
declin
number
new
patient
cdad
institut
polici
fail
discuss
signific
role
chang
housekeep
ing
hand
wash
glove
wear
educ
etc
occur
respons
outbreak
cdad
institut
author
also
endors
c
diffcil
toxin
test
test
cure
publish
data
support
content
stool
specimen
asympto
matic
patient
test
presenc
toxinproduc
c
dij
tile
effort
prevent
develop
diseas
result
colon
state
patient
asymptomat
colon
admiss
actual
low
risk
subsequ
develop
cdad
primari
symptomless
colon
may
provid
patient
protect
develop
cdad
pro
tection
appear
provid
toxigen
nontoxigen
strain
publish
data
also
support
test
stool
specimen
asymptomat
patient
presenc
toxigen
c
dsfficil
effort
prevent
noso
comial
transmiss
organ
everi
patient
hospit
acquir
c
cile
risk
develop
cdad
clinic
symp
tom
develop
hospit
patient
becom
colon
shea
positionpap
remind
us
transmiss
infec
tion
patient
associ
ongo
diarrhea
men
